| Literature DB >> 35309042 |
Rald V M Groven1,2, Sylvia P Nauta3,4, Jane Gruisen1,3, Britt S R Claes3, Johannes Greven5, Martijn van Griensven2, Martijn Poeze1,6, Ron M A Heeren3, Tiffany Porta Siegel3, Berta Cillero-Pastor3, Taco J Blokhuis1,6.
Abstract
Background: Fracture healing is a complex process, involving cell-cell interactions, various cytokines, and growth factors. Although fracture treatment improved over the last decades, a substantial part of all fractures shows delayed or absent healing. The fracture hematoma (fxh) is known to have a relevant role in this process, while the exact mechanisms by which it influences fracture healing are poorly understood. To improve strategies in fracture treatment, regulatory pathways in fracture healing need to be investigated. Lipids are important molecules in cellular signaling, inflammation, and metabolism, as well as key structural components of the cell. Analysis of the lipid spectrum in fxh may therefore reflect important events during the early healing phase. This study aims to develop a protocol for the determination of lipid signals over time, and the identification of lipids that contribute to these signals, with matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) in fxh in healthy fracture healing.Entities:
Keywords: MALDI-MSI; fracture healing; fracture hematoma; lipids; sample preparation
Year: 2022 PMID: 35309042 PMCID: PMC8927282 DOI: 10.3389/fchem.2021.780626
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
FIGURE 1General MALDI-MSI workflow, applied to fracture hematoma analysis. The fxh was surgically removed and snap frozen in liquid nitrogen. The fxh was cryo-sectioned and thaw mounted on ITO slides. The slides were washed by submerging them in either ammonium formate or acetone. Afterwards, norharmane was homogenously sprayed onto the slides. The coated slides were analyzed by MALDI-MSI after which the data were processed and visualized.
Overview of fxh tissues and ages used for the different objectives.
| Objective | fxh tissue | fxh age |
|---|---|---|
| Tissue washing comparison | 1 Human | 3 days |
| 1 Porcine | 3 days | |
| Intra-hematoma variability | 4 Porcine | 3 days |
| Detection of molecular patterns | 2 Human | 2 days |
| 2 Human | 9 days | |
| 2 Human | 19 days |
Overview of the different washing methods that were applied to the fxh, including the polarity.
| Washing solvent | Washing time | Negative ion mode | Positive ion mode |
|---|---|---|---|
| Ammonium formate | 30 s | X | X |
| 15 s twice | X | X | |
| 30 s twice | X | - | |
| 15 s four times | X | - | |
| Acetone | 30 s twice | X | X |
| 30 s four times | X | - | |
| No-wash (control) | - | X | X |
FIGURE 2Comparison of the ratios between heme and selected m/z values for different washing methods for negative and positive ion mode for porcine and human fracture hematoma. The ratios represent the ion intensities of selected m/z values over the heme ion intensity. The m/z values were selected based on the highest intensities (excluding isotopes) and to cover the mass range of lipids (m/z 650–950). (A) Ratios for 10 m/z values for the six washing methods and the control (no washing) for porcine fxh in negative ion mode. (B) Ratios for 10 m/z values for the three washing methods and the control (no washing) for porcine fxh in positive ion mode. (C) Ratios for 10 m/z values for the six washing methods and the control (no washing) for human fxh in negative ion mode. (D) Ratios for 10 m/z values for the three washing methods and the control (no washing) for human fxh in positive ion mode.
FIGURE 3H&E stained and MALDI-MSI distribution images for three different washing methods for human fxh. MALDI-MSI images are shown for the distribution of heme (m/z 615.2) and lipids with m/z values 885.6 and 788.6 in negative ion mode for the washing methods: ammonium formate for 30 s (left column), ammonium formate for 15 s twice (middle column), and acetone for 30 s twice (right column). All shown intensities are total ion current (TIC) normalized.
FIGURE 4DF-1 scores for comparison of the intra-variability of fracture hematoma for negative and positive ion mode. The DF-1 score explains the biggest variance in the data set as determined by a PCA-LDA of the mass spectra of the outside and center sections of different porcine fxh. (A) DF-1 score for the outside and center sections of four porcine fxh in negative ion mode. (B) DF-1 score for the outside and center sections of four porcine fxh in positive ion mode.
FIGURE 5Results of the PCA-LDA of the human fxh of different fxh age (2, 9, and 19 days) for negative ion mode. DF-scores and their corresponding scaled loading plots are shown. The scaled loading is a combination of the intensity of the m/z value with how much the molecule contributes to the separation of classes across the specified discriminant function. The positive side for the DF-score plot is related to the positive side of the scaled loading plots. This indicates that the m/z values at a certain side have a higher contribution in the class at that side. (A) DF-1 score representing the first discriminant function, which corresponds to the highest variance in the dataset. (B) The DF-2 score representing the second discriminant function. (C) Scaled loading plot of the full mass range for DF-1. (D) Scaled loading plot of the full mass range for DF-2.
Lipid assignments based on MS/MS data and high mass resolution experiments in negative ion mode. For each assignment, the m/z value obtained with the high mass resolution mass spectrometer (Orbitrap Elite), the lipid assignment, the detected ion, the ppm error, the condition to which the m/z value contributes, the DF, and the corresponding scaled loading are provided.
|
| Assignment | Ion | Δ ppm error | Condition | DF |
|---|---|---|---|---|---|
| 687.54 | SM 16:0_18:1; O2 | [M-CH3]- | 0.5 | Day 2 | DF-1 |
| 699.50 | PA 18:0_18:2 and PA 18:1_18:1 | [M-H]- | 0.5 | Day 19 | DF-1 |
| 701.51 | PA 18:0_18:1 | [M-H]- | 0.5 | Day 2 | DF-1 |
| Day 9 | DF-2 | ||||
| 716.52 | PE 16:0_18:1 | [M-H]- | 0.7 | Day 9 | DF-2 |
| 723.50 | PA 18:0_20:4 | [M-H]- | 0.4 | Day 2 | DF-1 |
| Day 9 | DF-2 | ||||
| 742.54 | PE 18:0_18:2 and PE 18:1_18:1 | [M-H]- | 0.5 | Day 9 | DF-2 |
| 744.60 | PE 18:0_18:1 | [M-H]- | 0.6 | Day 9 | DF-2 |
| 766.54 | PE 18:0_20:4 | [M-H]- | 0.9 | Day 2 | DF-1 |
| 770.57 | PE 18:0_20:2 and PE 18:1_20:1 and PE 18:2_20:0 | [M-H]- | 1.8 | Day 9 | DF-2 |
| 786.53 | PS 18:0_18:2 and PS 18:1_18:1 | [M-H]- | 0.5 | Day 19 | DF-1 |
| 788.54 | PS 18:0_18:1 | [M-H]- | 0.6 | Day 2 | DF-1 |
| Day 9 | DF-2 | ||||
| 810.53 | PS 18:0_20:4 | [M-H]- | 0.5 | Day 2 | DF-1 |
| Day 9 | DF-2 | ||||
| 833.52 | PI 16:0_18:2 and PI 16:1_18:1 and PI 16:2_18:0 | [M-H]- | 0.6 | Day 9 | DF-2 |
| 835.53 | PI 16:1_18:0 and PI 16:0_18:1 | [M-H]- | 1.1 | Day 19 | DF-1 |
| Day 9 | DF-2 | ||||
| 859.53 | PI 18:1_18:2 | [M-H]- | 0.1 | Day 19 | DF-1 |
| 861.54 | PI 18:0_18:2 and PI 18:1_18:1 | [M-H]- | 0.6 | Day 19 | DF-1 |
| Day 9 | DF-2 | ||||
| 863.56 | PI 18:0_18:1 | [M-H]- | 0.8 | Day 19 | DF-1 |
| Day 9 | DF-2 | ||||
| 883.53 | PI 18:1_20:4 | [M-H]- | 0.8 | Day 19 | DF-1 |
| Day 2 | DF-2 | ||||
| 885.55 | PI 18:0_20:4 | [M-H]- | 0.8 | Day 19 | DF-1 |
| Day 2 | DF-2 | ||||
| 909.55 | PI 18:0_22:6 | [M-H]- | 0.9 | Day 19 | DF-1 |
| 911.56 | PI 18:0_22:5 and PI 18:1_22:4 | [M-H]- | 1.0 | Day 19 | DF-1 |
| 1447.96 | CL 18:2_18:2_18:2_18:2 | [M-H]- | 0.4 | Day 19 | DF-1 |
| Day 2 | DF-2 | ||||
| 1449.98 | CL 18:1_18:2_18:2_18:2 | [M-H]- | 1.0 | Day 19 | DF-1 |
FIGURE 6Results of the PCA-LDA of the human fxh of different fxh age (2, 9, and 19 days) for positive ion mode. DF-scores and their corresponding scaled loading plots are shown. The scaled loading is a combination of the intensity of the m/z value with how much the molecule contributes to the separation of classes across the specified discriminant function. The positive side for the DF-score plot is related to the positive side of the scaled loading plots. This indicates that the m/z values at a certain side have a higher contribution in the class at that side. (A) DF-1 score representing the first discriminant function, which corresponds to the highest variance in the dataset. (B) The DF-2 score representing the second discriminant function. (C) Scaled loading plot of the full mass range for DF-1. (D) Scaled loading plot of the full mass range for DF-2.
Lipid assignments based on MS/MS and high mass resolution experiments in positive ion mode. For each assignment, the m/z value obtained with the high mass resolution mass spectrometer (Orbitrap Elite), the lipid assignment, the detected ion, the ppm error, the condition to which the m/z value contributes, the DF, and the corresponding scaled loading are provided.
|
| Assignment | Ion | Δ ppm error | Condition | DF |
|---|---|---|---|---|---|
| 400.34 | CAR 16:0 | [M + H]+ | 1.0 | Day 2 + 19 | DF-2 |
| 426.36 | CAR 18:1 | [M + H]+ | 0.4 | Day 2 + 19 | DF-2 |
| 496.34 | LPC 16:0 | [M + H]+ | 0.7 | Day 2 | DF-1 |
| Day 9 | DF-2 | ||||
| 524.37 | LPC 18:0 | [M + H]+ | 1.5 | Day 2 | DF-1 |
| 703.57 | SM 34:1; O2 | [M + H]+ | 0.4 | Day 9 | DF-2 |
| 734.57 | PC 16:0_16:0 | [M + H]+ | 0.4 | Day 19 | DF-1 |
| Day 2 + 19 | DF-2 | ||||
| 758.57 | PC 16:0_18:2 | [M + H]+ | 0.5 | Day 2 | DF-1 |
| Day 9 | DF-2 | ||||
| 760.58 | PC 16:0_18:1 | [M + H]+ | 0.7 | Day 19 | DF-1 |
| Day 9 | DF-2 | ||||
| 768.59 | PC O-36:4 | [M + H]+ | 0.7 | Day 2 | DF-1 |
| 782.57 | PC 16:0_20:4 | [M + H]+ | 0.6 | Day 2 | DF-1 |
| Day 9 | DF-2 | ||||
| 784.58 | PC 16:0_20:3 and PC 18:1_18:2 | [M + H]+ | 0.7 | Day 19 | DF-1 |
| 786.60 | PC 18:0_18:2 and PC 18:1_18:1 | [M + H]+ | 0.7 | Day 19 | DF-1 |
| Day 2 + 19 | DF-2 | ||||
| 788.62 | PC 18:0_18:1 | [M + H]+ | 1.4 | Day 2 | DF-1 |
| 810.60 | PC 18:0_20:4 | [M + H]+ | 0.7 | Day 2 | DF-1 |